Cell Processing Technologies Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Cell Processing Technologies Market Through 2025?
In recent years, there has been a significant increase in the size of the market for cell processing technologies. The market, currently valued at $4.29 billion in 2024, is projected to rise to $4.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.0%. Factors contributing to growth during the historic period include a greater adoption of manual cell processing methods, an increased interest in cell biology research within academia, the implementation of early stem cell banking initiatives, a stronger dependency on basic laboratory centrifugation tools, and a growing need for cell culture reagents in research efforts.

What's the Projected Size of the Global Cell Processing Technologies Market by 2029?
The market size for cell processing technologies is anticipated to experience a swift expansion in the forthcoming years. It is projected to rise to $8.15 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The escalation during the projected period can be ascribed to a rising demand for customized cell therapies, an upsurge in investments towards cell manufacturing infrastructure, amplified public and private sector funding, and an increment in clinical trials concerning cell-based therapies. Key trends expected in the forecasted period entail the evolution of smart bioreactor technologies, the creation of entirely automated cell manufacturing systems, innovation in solitary-cell analysis platforms, progress in AI-powered quality control solutions, and the establishment of integrated closed-loop processing workflows.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-processing-technologies-global-market-report

Top Growth Drivers in the Cell Processing Technologies Industry: What's Accelerating the Market?
The growth of the cell processing technologies market is predicted to be fuelled by the increased implementation of personalized medicine. Personalized medicine caters treatments to individual patients by taking into account their genetic, environmental, and lifestyle considerations, aiming to maximize successful outcomes and enhance patient care. There's a growing need for personalized medicine as genomic technologies progress, offering precise identification of genetic differences and bespoke treatments for individuals. The precision and preparation of patient-specific cells is enabled by cell processing technologies, making them crucial components of customised therapies. These technologies enhance treatment outcomes by ensuring high-quality, viable cells, which accelerates the development of targeted and effective healthcare solutions. For example, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the U.S., reported in February 2024 that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking an increase from the 12 approved in 2022. Therefore, the escalating use of customised therapies is propelling the cell processing technologies market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27243&type=smp

What Are the Key Trends Driving Cell Processing Technologies Market Growth?
Major businesses in the cell processing technologies market are devoting their resources to the development of technologically sophisticated solutions including automated cell therapy manufacturing platforms. These platforms enhance scalability, increase process efficiency and improve the quality of cells, all while lowering production expenses. An automated cell therapy manufacturing platform is a comprehensive system that uses high-end robotics, sensors, and software to manufacture cell-based therapies with the least amount of manual involvement. As an example, Limula SA, a life sciences company based in Switzerland, introduced LimONE in March 2025. This is a fully automated cell therapy manufacturing platform intended to revolutionize the creation of advanced therapies such as CAR-T and gene-edited stem cells. It simplifies intricate manufacturing procedures by incorporating a bioreactor and centrifuge into a solitary, enclosed device that operates on a single consumable throughout all stages of development. LimONE equips hospitals, biotech companies, and manufacturers with the ability to speed up the shift from research to clinical trials and commercial manufacturing thus making personalized cell and gene therapies, which can save lives, more easily obtainable for patients.

What Are the Main Segments in the Cell Processing Technologies Market?
The cell processing technologies market covered in this report is segmented

1) By Product Type: Equipment, Consumables, Software
2) By Application: Oncology, Cardiovascular Disease, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Immune Diseases, Other Applications
3) By End-User: Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End-Users

Subsegments:
1) By Equipment: Bioreactors, Centrifuges, Cell Counters, Incubators, Cryopreservation Systems, Cell Washers, Cell Sorters, Microscopes
2) By Consumables: Cell Culture Media, Reagents, Pipettes and Tips, Flasks and Plates, Cryovials, Filters, Disposable Bags, Tubes and Containers
3) By Software: Process Monitoring Software, Data Management Software, Automation Control Software, Quality Control Software, Imaging and Analysis Software, Inventory Management Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27243&type=smp

Which Top Companies are Driving Growth in the Cell Processing Technologies Market?
Major companies operating in the cell processing technologies market are Thermo Fisher Scientific Inc., Fresenius SE, Danaher Corporation, Cryo-Cell International Inc., Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Lonza Group AG, Terumo Corporation, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., Americord Registry LLC, Bio-Rad Laboratories Inc., PHC Holdings Corporation, Bio-Techne Corporation, StemCell Technologies Inc., Shibuya Corporation, Repligen Corporation, Beckman Coulter Inc., ThermoGenesis Holdings Inc., Ori Biotech Ltd., Biospherix Ltd., Miltenyi Biotec B.V. & Co. KG.

Which Regions Will Dominate the Cell Processing Technologies Market Through 2029?
North America was the largest region in the cell processing technologies market in 2024. The regions covered in the cell processing technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27243

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.